Endometriosis clinical trials
40 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Histologic Comparison of Ablative Techniques for Endometriosis
- Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
- Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
- Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
- The Impact of Yoga on Endometriosis-Related Pain
- Stanford Program to Accelerate Robotic Children's Surgery
- A Randomized Controlled Trial of a Nutritional Intervention for Endometriosis
- Cardiovascular Disease Risk in Women With Endometriosis
- The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
- Physical Therapy After Endometriosis Excision
- Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
- Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups
- Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
- Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
- Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
- Endometriosis and Migraine
- Endometriosis Pain
- Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
- Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
- Screening and Staging of Benign vs Malignant Pelvic Abnormalities
- Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
- Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
- Impact of Pelvic Pain Podcast
- Endometriosis and Microvascular Dysfunction: Role of Inflammation
- Feasibility of a Mindfulness Intervention for Endometriosis Surgery
- Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis
- Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
- Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis
- Research OutSmarts Endometriosis II Study
- RNA Assays for Endometriosis Detection and Diagnosis
- PET/MRI for Evaluation of Endometriosis
- Vaginal Ecosystem and Network in the United States Study
- Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
- Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
- Glycemic Regulation as Endometriosis Adjunct Treatment
- Nutritional Intervention for Endometriosis
- Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Endometriosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.